Search research articles
Contact Us
Filters
Showing results (31-40 of 53) with videos related to
Page
of 6
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 5, 2008
Phase I/II study of atrasentan, an endothelin A receptor antagonist, in combination with paclitaxel and carboplatin as first-line therapy in advanced non-small cell lung cancer
Alberto A Chiappori, Eric Haura, Francisco A Rodriguez, et al.
FEBS Open Bio
|
July 18, 2019
Characterization of epidermal growth factor receptor (EGFR) P848L, an unusual EGFR variant present in lung cancer patients, in a murine Ba/F3 model
Bhaswati Sarcar, Nicholas T Gimbrone, Gabriela Wright, et al.
Cancer Immunology, Immunotherapy : CII
|
December 29, 2018
Randomized-controlled phase II trial of salvage chemotherapy after immunization with a TP53-transfected dendritic cell-based vaccine (Ad.p53-DC) in patients with recurrent small cell lung cancer
Alberto A Chiappori, Charles C Williams, Jhanelle E Gray, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 4, 2007
A phase I pharmacokinetic and pharmacodynamic study of s-3304, a novel matrix metalloproteinase inhibitor, in patients with advanced and refractory solid tumors
Alberto A Chiappori, S Gail Eckhardt, Ronald Bukowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 24, 2006
Phase I study of the taxane BMS-188797 in combination with carboplatin administered every 3 weeks in patients with solid malignancies
Mayer N Fishman, Christopher R Garrett, George R Simon, et al.
The Oncologist
|
October 4, 2016
A Randomized Phase II Study of Linsitinib (OSI-906) Versus Topotecan in Patients With Relapsed Small-Cell Lung Cancer
Alberto A Chiappori, Gregory A Otterson, Afshin Dowlati, et al.
Sarcoma
|
February 17, 2016
Long-Term Clinical Responses of Neoadjuvant Dendritic Cell Infusions and Radiation in Soft Tissue Sarcoma
Shailaja Raj, Marilyn M Bui, Gregory Springett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 3, 2007
Phase I trial of poly-L-glutamate camptothecin (CT-2106) administered weekly in patients with advanced solid malignancies
Jade Homsi, George R Simon, Chris R Garrett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 2007
Multicenter, randomized, phase II trial of CI-1033, an irreversible pan-ERBB inhibitor, for previously treated advanced non small-cell lung cancer
Pasi A Jänne, Joachim von Pawel, Roger B Cohen, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 27, 2023
A phase I/IB trial of binimetinib in combination with erlotinib in NSCLC harboring activating KRAS or EGFR mutations
Andreas N Saltos, Ben C Creelan, Tawee Tanvetyanon, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 53) with videos related to
Sort By:
Page
of 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 5, 2008
Phase I/II study of atrasentan, an endothelin A receptor antagonist, in combination with paclitaxel and carboplatin as first-line therapy in advanced non-small cell lung cancer
Alberto A Chiappori, Eric Haura, Francisco A Rodriguez, et al.
FEBS Open Bio
|
July 18, 2019
Characterization of epidermal growth factor receptor (EGFR) P848L, an unusual EGFR variant present in lung cancer patients, in a murine Ba/F3 model
Bhaswati Sarcar, Nicholas T Gimbrone, Gabriela Wright, et al.
Cancer Immunology, Immunotherapy : CII
|
December 29, 2018
Randomized-controlled phase II trial of salvage chemotherapy after immunization with a TP53-transfected dendritic cell-based vaccine (Ad.p53-DC) in patients with recurrent small cell lung cancer
Alberto A Chiappori, Charles C Williams, Jhanelle E Gray, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 4, 2007
A phase I pharmacokinetic and pharmacodynamic study of s-3304, a novel matrix metalloproteinase inhibitor, in patients with advanced and refractory solid tumors
Alberto A Chiappori, S Gail Eckhardt, Ronald Bukowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 24, 2006
Phase I study of the taxane BMS-188797 in combination with carboplatin administered every 3 weeks in patients with solid malignancies
Mayer N Fishman, Christopher R Garrett, George R Simon, et al.
The Oncologist
|
October 4, 2016
A Randomized Phase II Study of Linsitinib (OSI-906) Versus Topotecan in Patients With Relapsed Small-Cell Lung Cancer
Alberto A Chiappori, Gregory A Otterson, Afshin Dowlati, et al.
Sarcoma
|
February 17, 2016
Long-Term Clinical Responses of Neoadjuvant Dendritic Cell Infusions and Radiation in Soft Tissue Sarcoma
Shailaja Raj, Marilyn M Bui, Gregory Springett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 3, 2007
Phase I trial of poly-L-glutamate camptothecin (CT-2106) administered weekly in patients with advanced solid malignancies
Jade Homsi, George R Simon, Chris R Garrett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 2007
Multicenter, randomized, phase II trial of CI-1033, an irreversible pan-ERBB inhibitor, for previously treated advanced non small-cell lung cancer
Pasi A Jänne, Joachim von Pawel, Roger B Cohen, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 27, 2023
A phase I/IB trial of binimetinib in combination with erlotinib in NSCLC harboring activating KRAS or EGFR mutations
Andreas N Saltos, Ben C Creelan, Tawee Tanvetyanon, et al.
Page
of 6